Cardiac gene therapy represents a cutting-edge approach in the realm of cardiovascular medicine, holding immense promise for the treatment of various heart-related conditions. This innovative therapeutic strategy involves the introduction of specific genes into the heart with the aim of correcting or modulating genetic defects, enhancing myocardial function, and mitigating the progression of cardiac diseases. By leveraging the potential of gene delivery systems, researchers are exploring avenues to address conditions such as heart failure, hypertrophic cardiomyopathy, and other genetic cardiovascular disorders. The evolving field of cardiac gene therapy signifies a paradigm shift, offering hope for more targeted and personalized interventions in the quest for improved heart health. As scientists continue to unravel the complexities of cardiac genetics, the potential for groundbreaking advancements in treating cardiovascular diseases through gene-based approaches remains a captivating area of exploration and development.
Title : Surgical fetal stem cells implantation in heart failure patients long term results at 14 years
Federico Benetti, Benetti Foundation, Argentina
Title : Exploring new biomarkers of cardiomyopathy
Shuping Zhong, University of Southern California, United States
Title : The development of human relaxin-2 for heart failure with preserved ejection fraction, HFpEF
Thomas Bernd Dschietzig, Relaxera GmbH & Co. KG, Germany
Title : Cancer and cardiovascular diseases: Common pathogenesis mechanisms and risk factors
Mekhman N Mamedov, National Research Center for Preventive Medicine, Russian Federation
Title : Pulse field ablation for atrial fibrillation complications: What do we know yet
Narendra Kumar, HeartbeatsZ Academy, United Kingdom
Title : Lipoprotein (a): The hidden cardiovascular risk
Syed Raza, Awali Hospital, Bahrain